ABL1 and substance withdrawal syndrome: In this case, the potential for withdrawal syndrome [32], the importance of regular BCR::ABL1 monitoring, and a quick restart of therapy should levels rise would have been key discussion points, alongside the wish of the patient to prevent ongoing side effects and to stop taking medication every day.